critical-outcome-technologies-inc documents

Critical Outcome Investor Presentation - March 2014
Investor Relations Critical Outcome Investor Presentation - March 2014
Critical Outcome - Investor Update - July 2013
Investor Relations Critical Outcome - Investor Update - July 2013
Critical Outcome Technologies - Investor Presentation - June 2013
Investor Relations Critical Outcome Technologies - Investor Presentation - June 2013
Pathway to the clinic and beyond
Health & Medicine Pathway to the clinic and beyond
A promising advance for many cancers
Health & Medicine A promising advance for many cancers
Critical Outcome - Investor Presentation - January 2014
Health & Medicine Critical Outcome - Investor Presentation - January 2014
COTI-2 | Reactivating Mutant p53
Health & Medicine COTI-2 | Reactivating Mutant p53
Introducing ROSALIND
Health & Medicine Introducing ROSALIND
Critical Outcome Technologies Business & Scientific Updates
Health & Medicine Critical Outcome Technologies Business & Scientific Updates
Critical Outcome BIO Investor Forum
Business Critical Outcome BIO Investor Forum
Critical Outcome - September 2014
Health & Medicine Critical Outcome - September 2014
Critical Outcome Technologies at the BIO Investor Forum 2014
Investor Relations Critical Outcome Technologies at the BIO Investor Forum 2014
More than just a potential BREAKTHROUGH treatment for many cancers
Health & Medicine More than just a potential BREAKTHROUGH treatment for many cancers
Small-Cap Stars
Investor Relations Small-Cap Stars
COTI Overview
Investor Relations COTI Overview
Business and Scientific Update
Investor Relations Business and Scientific Update
2016 Annual General & Special Meeting of Shareholders
Investor Relations 2016 Annual General & Special Meeting of Shareholders
Critical Outcome investor presentation - November 2015
Health & Medicine Critical Outcome investor presentation - November 2015
COTI Corporate Presentation at Cantech 2017
Investor Relations COTI Corporate Presentation at Cantech 2017
Introducing ROSALIND
Health & Medicine Introducing ROSALIND
ROSALIND at 48 Hours in the Hub
Health & Medicine ROSALIND at 48 Hours in the Hub